• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta recognized on national and Seattle LinkedIn Top Startup 2024 lists

Truveta recognized on national and Seattle LinkedIn Top Startup 2024 lists

by Truveta News | Oct 9, 2024 | News

Today, Truveta was featured as #3 on LinkedIn’s inaugural Top Startups in Seattle list. The ranking highlights ten growing start-up companies in the Seattle area.   Last month, Truveta was also included on the national LinkedIn’s Top Startups list for 2024, which...
Case study: De-risking clinical development and driving therapeutic innovation in heart failure

Case study: De-risking clinical development and driving therapeutic innovation in heart failure

by Truveta staff | Sep 26, 2024 | Technology

Despite advances in guideline-directed medical therapy, heart failure (HF) readmission rates have worsened over the past decade. Optimizing acute inpatient decongestion is critical in mitigating HF morbidity and mortality, but few new treatment strategies have emerged...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through August 2024

Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through August 2024

by Truveta staff | Sep 19, 2024 | Research

Overall, the rate of hospitalizations associated with respiratory viruses remained stable throughout August 2024, with no change compared to July 2024. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased significantly...
Real-time monitoring of viral gastroenteritis: August 2024

Real-time monitoring of viral gastroenteritis: August 2024

by Truveta staff | Sep 11, 2024 | Research

The overall trends of hospitalizations associated with viral gastroenteritis – norovirus and rotavirus – show a steady decrease over the last few months, leading to a rate of 0.04% in August 2024 in the overall population. However, we see first indicators that the...
ISPE 2024: Exploring the impact of removing race as a diagnostic factor for chronic kidney disease: Time to potassium-lowering drugs

ISPE 2024: Exploring the impact of removing race as a diagnostic factor for chronic kidney disease: Time to potassium-lowering drugs

by Truveta Research | Aug 23, 2024 | Research, Research Insights

Authors: Charlotte Baker DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc, Bellevue, WA, Samuel Gratzl PhD ⊕Truveta, Inc, Bellevue, WA, Nicholas Stucky, MD PhD ⊕Truveta,...
« Older Entries
Next Entries »

Share this


Recent posts

  • Lyme disease peaks in June, remains high through August
  • Infection risk and adoption trends in hemodialysis catheters: New real-world evidence
  • GLP-1 RA prescription trends: January 2018 – June 2025

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.